BeiGene Social Media Community Guidelines – NASDAQ (US) Website

BeiGene Social Media Community Guidelines

Our goals for BeiGene’s social media channels are to have productive communications and meaningful dialogues. We welcome questions and comments and aim to actively engage with the social media community. Currently, BeiGene has an official Twitter account and an official LinkedIn company page, both in English. In China we have an official WeChat account and an official Weibo page.

To ensure that our communications are consistent with our mission and legal and regulatory obligations, we have developed general guidelines. If you have any questions regarding our social media community guidelines, please contact us at media@beigene.com.

General Guidelines:

Adverse Events or Medical Side Effects

If your post includes possible side effects associated with a BeiGene product, we may be required to contact you for further information. U.S. patients may contact us to report an adverse event related to BeiGene products by emailing adverse_events@beigene.com or contacting the FDA directly via www.fda.gov/medwatch or  1-800-FDA-1088. Patients in China may contact us to report an adverse event related to BeiGene products by calling +86-400-820-3159 or they may contact their physician or pharmacist to report an adverse event. Patients located outside the U.S. and China should contact their health care provider for more information or contact their local health authority.

Click here for Social Media Community Guidelines in Chinese